Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
CRISPR Therapeutics(CRSP) The Motley Fool·2024-05-15 23:11
How much would you pay for a stock that might earn 1.43 -- more than twice the year-ago loss. And that's OK -- at least according to Oppenheimer analyst Jay Olson, who on Friday lowered his ...